ArticleInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society2023

Safety and activity of anti-mesothelin antibody-drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study.

Alessandro D Santin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.